In this article \[*Sleep*, Volume 42, Issue 4, April 2019, zsy260, [https://doi.org/10.1093/sleep/zsy260](10.1093/sleep/zsy260)\], in the Statistical analyses section of the Methods, the statistical test used in the symmetry analysis has been corrected from generalized sign tests to the McNemar test (page 4, column 2) and the sign for the increase in SDLP has been corrected from ≥ to \>. The following sentence has been corrected:

To perform this symmetry analysis, the McNemar test used for each treatment condition and treatment day separately to test whether the number of participants with an increase in SDLP \>2.4 cm (reflecting impairment) differed significantly (*p* \< 0.05) from the number of participants with a decrease in SDLP \< −2.4 cm (reflecting improvement).

A similar sign correction has been made to the SDLP section of the Results (page 5, column 2, paragraph 3).

The following corrections have also been made to [Table 2](#T2){ref-type="table"}. The column heading "Test statistic" has been corrected to "McNemar Test *P*-value" and the *P*-values have been expanded to three decimal places. Additionally, an error in the title has been corrected to include a missing minus sign and the signs in the ∆SDLP columns have been corrected from ≥ and ≤ to \> and \<. The corrected Table 2 is listed below. The authors regret the errors.

###### 

Symmetry analysis of numbers of participants whose SDLP increased more than 2.4 cm (indicating impairment) and numbers of participants whose SDLP decreased more than −2.4 cm (indicating improvement), *n* = 48

  Treatment condition   Day   ∆SDLP \> 2.4 *n* (proportion)   ∆SDLP \< −2.4 *n* (proportion)   McNemar test *P*-value   Reject H~0~
  --------------------- ----- ------------------------------- -------------------------------- ------------------------ -------------
  LEM2.5 (*n* = 32)     2     4 (12.5)                        2 (6.3)                          0.688                    No
                        9     6 (18.8)                        1 (3.1)                          0.125                    No
  LEM5 (*n* = 32)       2     4 (12.5)                        5 (15.6)                         1.000                    No
                        9     7 (21.9)                        1 (3.1)                          0.070                    No
  LEM10 (*n* = 32)      2     6 (18.8)                        3 (9.4)                          0.508                    No
                        9     6 (18.8)                        3 (9.4)                          0.508                    No
  ZOP (*n* = 48)        2     20 (41.7)                       1 (2.1)                          \<0.0001                 Yes
                        9     24 (50.0)                       3 (6.3)                          \<0.0001                 Yes

LEM2.5, lemborexant 2.5 mg; LEM5, lemborexant 5 mg; LEM10, lemborexant 10 mg; SDLP, standard deviation of lateral position; ZOP, zopiclone 7.5 mg.
